Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality

Alexander Tenenbaum*, Enrique Z. Fisman

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)52-53
Number of pages2
JournalEvidence-Based Medicine
Issue number2
StatePublished - Apr 2010

Cite this